Karus Therapeutics
Chilworth
About Karus Therapeutics
Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $14.8M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2016)
- Website: karustherapeutics.com
- Phone: 44-(0)2380-111-360
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/karus-therapeutics-2441943 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.